März W - Search Results

1

APRIL limits atherosclerosis by binding to heparan sulfate proteoglycans.

Tsiantoulas D, Eslami M, Obermayer G, Clement M, Smeets D, Mayer FJ, Kiss MG, Enders L, Weißer J, Göderle L, Lambert J, Frommlet F, Mueller A, Hendrikx T, Ozsvar-Kozma M, Porsch F, Willen L, Afonyushkin T, Murphy JE, Fogelstrand P, Donzé O, Pasterkamp G, Hoke M, Kubicek S, Jørgensen HF, Danchin N, Simon T, Scharnagl H, März W, Borén J, Hess H, Mallat Z, Schneider P, Binder CJ. Tsiantoulas D, et al. Among authors: marz w. Nature. 2021 Sep;597(7874):92-96. doi: 10.1038/s41586-021-03818-3. Epub 2021 Aug 25. Nature. 2021. PMID: 34433968

2

Mechanisms of liver steatosis in rats with systemic carnitine deficiency due to treatment with trimethylhydraziniumpropionate.

Spaniol M, Kaufmann P, Beier K, Wüthrich J, Török M, Scharnagl H, März W, Krähenbühl S. Spaniol M, et al. Among authors: marz w. J Lipid Res. 2003 Jan;44(1):144-53. doi: 10.1194/jlr.m200200-jlr200. J Lipid Res. 2003. PMID: 12518033 Free article.

3

Effect of Helicobacter pylori eradication on high-density lipoprotein cholesterol.

Scharnagl H, Kist M, Grawitz AB, Koenig W, Wieland H, März W. Scharnagl H, et al. Among authors: marz w. Am J Cardiol. 2004 Jan 15;93(2):219-20. doi: 10.1016/j.amjcard.2003.09.045. Am J Cardiol. 2004. PMID: 14715353 Clinical Trial.

4

Double-blind, randomized study comparing the effects of two monophasic oral contraceptives containing ethinylestradiol (20 microg or 30 microg) and levonorgestrel (100 microg or 150 microg) on lipoprotein metabolism.

Scharnagl H, Petersen G, Nauck M, Teichmann AT, Wieland H, März W. Scharnagl H, et al. Among authors: marz w. Contraception. 2004 Feb;69(2):105-13. doi: 10.1016/j.contraception.2003.10.004. Contraception. 2004. PMID: 14759614 Clinical Trial.

5

The apolipoprotein E polymorphism is associated with circulating C-reactive protein (the Ludwigshafen risk and cardiovascular health study).

März W, Scharnagl H, Hoffmann MM, Boehm BO, Winkelmann BR. März W, et al. Eur Heart J. 2004 Dec;25(23):2109-19. doi: 10.1016/j.ehj.2004.08.024. Eur Heart J. 2004. PMID: 15571826

6

ApoE: crossroads between Alzheimer's disease and atherosclerosis.

Stojakovic T, Scharnagl H, März W. Stojakovic T, et al. Among authors: marz w. Semin Vasc Med. 2004 Aug;4(3):279-85. doi: 10.1055/s-2004-861496. Semin Vasc Med. 2004. PMID: 15630629 Review.

7

New lipid-lowering agents acting on LDL receptors.

Scharnagl H, März W. Scharnagl H, et al. Among authors: marz w. Curr Top Med Chem. 2005;5(3):233-42. doi: 10.2174/1568026053544524. Curr Top Med Chem. 2005. PMID: 15857307 Review.

8

Free fatty acids are independently associated with all-cause and cardiovascular mortality in subjects with coronary artery disease.

Pilz S, Scharnagl H, Tiran B, Seelhorst U, Wellnitz B, Boehm BO, Schaefer JR, März W. Pilz S, et al. Among authors: marz w. J Clin Endocrinol Metab. 2006 Jul;91(7):2542-7. doi: 10.1210/jc.2006-0195. Epub 2006 Apr 4. J Clin Endocrinol Metab. 2006. PMID: 16595593

9

Efficacy and safety of fluvastatin-extended release in hypercholesterolemic patients: morning administration is equivalent to evening administration.

Scharnagl H, Vogel M, Abletshauser C, Freisinger F, Stojakovic T, März W. Scharnagl H, et al. Among authors: marz w. Cardiology. 2006;106(4):241-8. doi: 10.1159/000093200. Epub 2006 May 10. Cardiology. 2006. PMID: 16691029 Clinical Trial.

10

Low density lipoprotein triglycerides and lipoprotein(a) are risk factors for retinal vascular occlusion.

Stojakovic T, Scharnagl H, März W, Winkelmann BR, Boehm BO, Schmut O. Stojakovic T, et al. Among authors: marz w. Clin Chim Acta. 2007 Jul;382(1-2):77-81. doi: 10.1016/j.cca.2007.03.024. Epub 2007 Apr 12. Clin Chim Acta. 2007. PMID: 17481600

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

882 results

Search Page